companydata.dkcompanydata.dk

Atnahs Pharma Denmark ApS: Financial statements 2022

CVR: 36699051

Source: annual report 2022, Danish Business Authority

01/04/2021 – 31/03/2022

Atnahs Pharma Denmark ApS (CVR 36699051) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 9,761,758 and a net result of DKK 3,647,068 compared with DKK 275,303 the year before. That is an increase of 91.7% compared with the year before. Equity in the 2022 report amounted to DKK 142,279. The solvency ratio was 0.1%.

Gross Profit
DKK 9,761,758
Profit/Loss
DKK 3,647,068
Equity
DKK 142,279
Total Assets
DKK 202,928,043

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-9.8 mio.3.6 mio.142 t.-
2021-5.1 mio.275 t.-3.5 mio.-
2020--1.3 mio.-1.4 mio.-3.8 mio.-
2019-779 t.-1.1 mio.-2.4 mio.-
2018--1.4 mio.-1.9 mio.-1.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Atnahs Pharma Denmark ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Rishi Bhikhu leaves the board of Atnahs Pharma Denmark ApSMar 29, 2022

As of March 29, 2022, Rishi Bhikhu has left the board of directors of Atnahs Pharma Denmark ApS.

About Atnahs Pharma Denmark ApS

Atnahs Pharma Denmark ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Pharmamentum ApS. The management consists of Christoph Michael Habereder. The board consists of Mohammad Muqtadir Samy (chair), Christoph Michael Habereder and Twan Johannes Anna Nouwen. The company is owned by Atnahs Pharma UK Limited. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported revenue of EUR 52,583,756 and a net result of EUR 12,487 compared with DKK 47,843 the year before. Equity in the 2026 report amounted to EUR 2,094,136.

Source: annual report 2026, Danish Business Authority